Aeglea BioTherapeutics Investor Presentation Deck

SPY001 is designed for fully SC induction dosing with upside efficacy potential SPY001 INDUCTION DOSING PROFILE VEDOLIZUMAB SPYRE SC INDUCTION DOSING IV INDUCTION DOSING -Am WO WO Chil W2 b- W2 AM W6 W6 PATIENT-ADMINISTERED UPSIDE POTENTIAL FOR ENHANCED EFFICACY REQUIRES PHYSICIAN ADMINISTRATION / OFFICE VISIT POTENTIALLY UNDER-DOSED 17

View entire presentation